Sri Lanka, Jan. 21 -- The National Medicines Regulatory Authority (NMRA) has gone on alert amid concerns that Indian cancer drugs are being sold at exorbitant prices in private pharmacies.

Speaking to Daily Mirror, NMRA Chief Executive Officer Dr. Kumudu Bandara said the regulator is closely monitoring the situation following claims by health sector associations that unregistered Indian cancer medicines are freely available in pharmacies near major hospitals.

"The NMRA routinely carries out market surveillance to detect substandard or unregistered medicines. If a formal complaint is received regarding the availability of Indian cancer drugs, we will intensify surveillance and conduct targeted raids," Dr. Bandara said.

The issue was fla...